Seamus Patrick Caragher, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Duodenal Ulcer | 1 | 2022 | 121 | 0.830 |
Why?
|
| Glioblastoma | 5 | 2024 | 3480 | 0.630 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 485 | 0.530 |
Why?
|
| Embolization, Therapeutic | 2 | 2022 | 1407 | 0.520 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2016 | 53 | 0.510 |
Why?
|
| Dopamine | 2 | 2019 | 1599 | 0.470 |
Why?
|
| Aortic Coarctation | 1 | 2016 | 282 | 0.450 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 241 | 0.450 |
Why?
|
| Serotonin | 1 | 2018 | 1040 | 0.440 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 1094 | 0.340 |
Why?
|
| Students, Medical | 1 | 2021 | 1927 | 0.300 |
Why?
|
| Vascular Surgical Procedures | 1 | 2016 | 1470 | 0.290 |
Why?
|
| Brain Neoplasms | 4 | 2024 | 8981 | 0.270 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2022 | 47 | 0.210 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2024 | 345 | 0.200 |
Why?
|
| Hepatic Artery | 1 | 2022 | 230 | 0.190 |
Why?
|
| Phthalazines | 1 | 2024 | 382 | 0.190 |
Why?
|
| Aneurysm, Infected | 1 | 2022 | 81 | 0.190 |
Why?
|
| Duodenum | 1 | 2022 | 485 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2019 | 23341 | 0.160 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2019 | 58 | 0.160 |
Why?
|
| Cultural Diversity | 1 | 2021 | 365 | 0.140 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 480 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 2022 | 459 | 0.140 |
Why?
|
| Wisconsin | 1 | 2016 | 122 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2019 | 696 | 0.130 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 1110 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13591 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 611 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2021 | 877 | 0.120 |
Why?
|
| Tubulin | 1 | 2017 | 692 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1136 | 0.100 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2017 | 914 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2022 | 1276 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 16886 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2443 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 3480 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 2139 | 0.080 |
Why?
|
| Reoperation | 1 | 2016 | 4282 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3754 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8426 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2019 | 3602 | 0.050 |
Why?
|
| Humans | 10 | 2024 | 758381 | 0.050 |
Why?
|
| Animals | 5 | 2019 | 167777 | 0.050 |
Why?
|
| Registries | 1 | 2016 | 8176 | 0.040 |
Why?
|
| Male | 4 | 2022 | 358742 | 0.040 |
Why?
|
| Mice | 3 | 2019 | 81107 | 0.040 |
Why?
|
| Neurons | 1 | 2017 | 9418 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 69 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2017 | 153 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26182 | 0.030 |
Why?
|
| Indoles | 1 | 2024 | 1828 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1610 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1060 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5781 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 36054 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2022 | 64379 | 0.030 |
Why?
|
| Piperazines | 1 | 2024 | 2511 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42058 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80170 | 0.020 |
Why?
|
| Microtubules | 1 | 2017 | 1072 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 996 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3574 | 0.020 |
Why?
|
| Female | 3 | 2019 | 390316 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1972 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 2577 | 0.020 |
Why?
|
| Child | 1 | 2016 | 79813 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8144 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20052 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4342 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5248 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18942 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23681 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9273 | 0.010 |
Why?
|